[PDF][PDF] European intergroup studies (MMT4-89 and MMT4-91) on childhood metastatic rhabdomyosarcoma: final results and analysis of prognostic factors
M Carli, R Colombatti, O Oberlin… - Journal of Clinical …, 2004 - researchgate.net
M Carli, R Colombatti, O Oberlin, G Bisogno, J Treuner, E Koscielniak, G Tridello…
Journal of Clinical Oncology, 2004•researchgate.netEuropean Intergroup Studies (MMT4-89 and MMT4-91) on Childhood Metastatic
Rhabdomyosarcoma: Final Results and Analysis of Progno Page 1 European Intergroup
Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results
and Analysis of Prognostic Factors M. Carli, R. Colombatti, O. Oberlin, G. Bisogno, J. Treuner, E.
Koscielniak, G. Tridello, A. Garaventa, R. Pinkerton, and M. Stevens A B S T R A C T Purpose
Final results are presented from two consecutive European studies for patients with metastatic …
Rhabdomyosarcoma: Final Results and Analysis of Progno Page 1 European Intergroup
Studies (MMT4-89 and MMT4-91) on Childhood Metastatic Rhabdomyosarcoma: Final Results
and Analysis of Prognostic Factors M. Carli, R. Colombatti, O. Oberlin, G. Bisogno, J. Treuner, E.
Koscielniak, G. Tridello, A. Garaventa, R. Pinkerton, and M. Stevens A B S T R A C T Purpose
Final results are presented from two consecutive European studies for patients with metastatic …
Purpose
Final results are presented from two consecutive European studies for patients with metastatic rhabdomyosarcoma (RMS) to identify prognostic variables and determine the value of high-dose chemotherapy (HDCT) in complete remission.
researchgate.net
